Dave Cunningham

home / authors / dave-cunningham

Dave Cunningham is director, corporate development at Goodwin Biotechnology.

Articles

Optimizing a Unique Cancer Vaccine for Intradermal Delivery

Optimizing a Unique Cancer Vaccine for Intradermal Delivery

Muctarr Sesay;Mark Tomai;Steven Fuller;John Price;Dave Cunningham

September 15th 2017

Using a hollow microstructured transdermal system to deliver vaccine directly to the dermis.

Latest Updated Articles

Exploring New Advancements in ADC Technologies (CPHI Milan 2024)

Published: October 11th 2024 | Updated: March 3rd 2025

Exploring New Advancements in ADC Technologies (CPHI Milan 2024)

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

Published: September 11th 2024 | Updated: September 18th 2024

CPHI Pharma Award Finalists Announced for 2024

Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com

Published: March 27th 2024 | Updated: June 28th 2024

AbbVie Acquires Landos Biopharma and Gets Full FDA Nod for ADC Product

Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com

Published: July 25th 2025 | Updated: July 31st 2025

Trade Policy Shifts: Compliance and Cost Strategies for Pharma

OleksKao - stock.adobe.com

Published: July 28th 2025 | Updated: July 31st 2025

AstraZeneca’s Imfinzi Advances in Gastric Cancer With FDA Priority Review

Chris Hagen, SCIEX

Published: July 21st 2025 | Updated: July 31st 2025

Video Interview With Chris Hagen, President of SCIEX

Editorial Information

Do Not Sell My Personal Information

Terms and Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2025 MJH Life Sciences

All rights reserved.